InsidersTradesSigma
Follow the MicroPort CardioFlow Medtech Corporation - B share price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the oversight of HKEX. Operating in the Health Care sector, MicroPort CardioFlow Medtech Corporation - B has logged 4 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 15 May 2026 (Sale). Among the most active insiders: WANSTOK PHILIPPE. All data is openly available.
4
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€345,612
3 ops.
Sell Volume
21Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,511 of 29,064 companies
32.6
score / 100
Value29
Quality36
FCF yld-2.3%
Earn yld-1.1%
EV/EBITDA·
ROE-6.7%
Gross mgn65%
Net mgn-33%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 May 2026
Declarations4 total
400,000 shares@ HK$2.5910.060% mcap32.7% of flowShareXHKGHKEX:DA20260515E00004
400,000 shares@ HK$2.77970.065% mcap35.1% of flowShareXHKGHKEX:DA20260511E00419
339,000 shares@ HK$3.01960.059% mcap32.2% of flowShareXHKGHKEX:DA20260508E00632
143,920 sharesShareXHKGHKEX:DA20260426E00009
4 of 4 declarations
关于 MicroPort CardioFlow Medtech Corporation - B
MicroPort CardioFlow Medtech Corporation - B 是一家专注于开发心血管疾病治疗医疗技术的公司。该公司在香港证券交易所 (XHKG) 上市。